The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats

Neuroscience

Volumn 145, Issue 2, 2007, Pages 611-620

  Konieczny, J ^a   Wardas, J ^a   Kuter, K ^a   Pilc, A ^a   Ossowska, K ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

catalepsy; globus pallidus; in situ hybridization; mGluRs; striatum; substantia nigra pars reticulata

Indexed keywords

1 AMINOCYCLOPENTANE 1,3,4 TRICARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; CYCLOPENTANE DERIVATIVE; HALOPERIDOL; MESSENGER RNA; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST; PRODYNORPHIN; PROENKEPHALIN; UNCLASSIFIED DRUG;

AKINESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN REGION; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; GLOBUS PALLIDUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS RETICULATA; TERMINAL SEQUENCE; WISTAR RAT;

ANIMALS; CORPUS STRIATUM; CYCLOPENTANES; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALINS; EXCITATORY AMINO ACID AGONISTS; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HALOPERIDOL; MALE; NEURAL PATHWAYS; OPIOID PEPTIDES; PARKINSONIAN DISORDERS; PROTEIN PRECURSORS; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, MESSENGER; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TRICARBOXYLIC ACIDS; UP-REGULATION;

EID: 33847420602     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.12.006     Document Type: Article

References (62)

1. Angulo J.A. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. J Neurochem 58 (1992) 1104-1109
2. Battaglia G., Busceti C.L., Molinaro G., Biagioni F., Traficante A., Nicoletti F., and Bruno V. Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurosci 26 (2006) 7222-7229
3. Beckstead R.M. N-methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum. Synapse 21 (1995) 342-347
4. Bell M.I., Richardson P.J., and Lee K. Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneurones. J Neurochem 81 (2002) 142-149
5. Bevan M.D., Booth P.A., Eaton S.A., and Bolam J.P. Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. J Neurosci 18 (1998) 9438-9452
6. Bradley S.R., Marino M.J., Whittmann M., Rouse S.T., Levey A.I., and Conn P.J. Physiological roles of presynaptically localized type 2, 3 and 7 metabotropic glutamate receptors in the basal ganglia. Soc Neurosci Abstr 25 (1999) 176.16
7. Bradley S.R., Standaert D.G., Rhodes K.J., Rees H.D., Testa C.M., Levey A.I., and Conn P.J. Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia. J Comp Neurol 407 (1999) 33-46
8. Campbell K., and Bjorklund A. Prefrontal corticostriatal afferents maintain increased enkephalin gene expression in the dopamine-denervated rat striatum. Eur J Neurosci 6 (1994) 1371-1383
9. Cartmell J., and Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75 (2000) 889-907
10. Chadha A., Sur C., Atack J., and Duty S. The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat. Br J Pharmacol 130 (2000) 1927-1932
11. Corti C., Aldegheri L., Somogyi P., and Ferraguti F. Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 110 (2002) 403-420
12. Danysz W., Gossel M., Zaja{ogonek}czkowski W., Dill D., and Quack G. Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?. case of amantadine and memantine. J Neural Transm Park Dis Dement Sect 7 (1994) 155-166
13. Dewar D., Jenner P., and Marsden C.D. Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus. Neuroscience 15 (1985) 41-46
14. Dewar D., Jenner P., and Marsden C.D. Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus. Biochem Pharmacol 36 (1987) 1738-1741
15. Engber T.M., Boldry R.C., Kuo S., and Chase T.N. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res 581 (1992) 261-268
16. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., and Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
17. Gerfen C.R., McGinty J.F., and Young III W.S. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11 (1991) 1016-1031
18. Gerfen C.R., and Young III W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460 (1988) 161-167
19. Gross C.E., Boraud T., Guehl D., Bioulac B., and Bezard E. From experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research?. Prog Neurobiol 59 (1999) 509-532
20. Jiang H.K., McGinty J.F., and Hong J.S. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res 507 (1990) 57-64
21. Kawaguchi Y., Wilson C.J., Augood S.J., and Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 18 (1995) 527-535
22. Kinoshita A., Shigemoto R., Ohishi H., van der Putten H., and Mizuno N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J Comp Neurol 393 (1998) 332-352
23. Kobayashi T., Araki T., Itoyama Y., Takeshita M., Ohta T., and Oshima Y. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice. Life Sci 61 (1997) 2529-2538
24. Koos T., and Tepper J.M. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat Neurosci 2 (1999) 467-472
25. Kosinski C.M., Risso Bradley S., Conn P.J., Levey A.I., Landwehrmeyer G.B., Penney Jr. J.B., Young A.B., and Standaert D.G. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. J Comp Neurol 415 (1999) 266-284
26. Lindefors N. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Prog Neuropsychopharmacol Biol Psychiatry 17 (1993) 887-903
27. Lorenc-Koci E., Konieczny J., and Wolfarth S. Contribution of the glycine site of NMDA receptors in rostral and intermediate-caudal parts of the striatum to the regulation of muscle tone in rats. Brain Res 793 (1998) 315-320
28. MacInnes N., Messenger M.J., and Duty S. Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat. Br J Pharmacol 141 (2004) 15-22
29. Maj J., Rogóż Z., Skuza G., and Kołodziejczyk K. The behavioural effects of pramipexole, a novel dopamine receptor agonist. Eur J Pharmacol 324 (1997) 31-37
30. Maneuf Y.P., Mitchell I.J., Crossman A.R., and Brotchie J.M. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp Neurol 125 (1994) 65-71
31. Marino M.J., Williams Jr. D.L., O'Brien J.A., Valenti O., McDonald T.P., Clements M.K., Wang R., DiLella A.G., Hess J.F., Kinney G.G., and Conn P.J. Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment. Proc Natl Acad Sci U S A 100 (2003) 13668-13673
32. Matsui T., and Kita H. Activation of group III metabotropic glutamate receptors presynaptically reduces both GABAergic and glutamatergic transmission in the rat globus pallidus. Neuroscience 122 (2003) 727-737
33. Mavridis M., and Besson M.J. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression. Neuroscience 92 (1999) 945-966
34. Messenger M.J., Dawson L.G., and Duty S. Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract. Neuropharmacology 43 (2002) 261-271
35. Mizuno N. Analysis of neuronal connections in the basal ganglia. Rinsho Shinkeigaku 38 (1998) 977-982
36. Moldrich R.X., Chapman A.G., De Sarro G., and Meldrum B.S. Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol 476 (2003) 3-16
37. Moo-Puc R.E., Gongora-Alfaro J.L., Alvarez-Cervera F.J., Pineda J.C., Arankowsky-Sandoval G., and Heredia-Lopez F. Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy. Neuropharmacology 45 (2003) 493-503
38. Mörl F., Gröschel M., Leemhuis J., and Meyer D.K. Intrinsic GABA neurons inhibit proenkephalin gene expression in slice cultures of rat neostriatum. Eur J Neurosci 15 (2002) 1115-1124
39. Morris B.J., Hollt V., and Herz A. Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: contrasting effects of D1 and D2 antagonists. Neuroscience 25 (1988) 525-532
40. Noailles P.A., Villegas M., Ledoux M., Lucas L.R., McEwen B.S., and Angulo J.A. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain. Neurosci Lett 202 (1996) 165-168
41. Ossowska K. The role of excitatory amino acids in experimental models of Parkinson's disease. J Neural Transm [P-D Sect] 8 (1994) 39-71
42. Ossowska K., Konieczny J., Pilc A., and Wolfarth S. The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors. Brain Res 950 (2002) 88-94
43. Ossowska K., Pietraszek M., Wardas J., and Wolfarth S. Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist. Pol J Pharmacol 56 (2004) 295-304
44. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20 (1995) 128-154
45. Paxinos G., and Watson C. The rat brain in stereotactic coordinates (1986), Academic Press, San Diego
46. Peterson M.R., and Robertson H.A. Effect of dopaminergic agents on levels of dynorphin1-8 in rat striatum. Prog Neuropsychopharmacol Biol Psychiatry 8 (1984) 725-728
47. Pisani A., Calabresi P., Centonze D., and Bernardi G. Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse. Neuropharmacology 36 (1997) 845-851
48. Reimer S., Sirinathsinghji D.J., Nikolorakis K.E., and Hollt V. Differential dopaminergic regulation of proenkephalin and prodynorphin mRNAs in the basal ganglia of rats. Brain Res Mol Brain Res 12 (1992) 259-266
49. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 299 (2001) 12-20
50. Schroeder J.A., and Schneider J.S. GABA-opioid interactions in the globus pallidus: [D-Ala2]-Met-enkephalinamide attenuates potassium-evoked GABA release after nigrostriatal lesion. J Neurochem 82 (2002) 666-673
51. Shiozaki S., Ichikawa S., Nakamura J., Kitamura S., Yamada K., and Kuwana Y. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP. Psychopharmacology (Berl) 147 (1999) 90-95
52. Somers D.L., and Beckstead R.M. N-methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum. J Pharmacol Exp Ther 262 (1992) 823-833
53. Stanford I.M., and Cooper A.J. Presynaptic mu and delta opioid receptor modulation of GABAA IPSCs in the rat globus pallidus in vitro. J Neurosci 19 (1999) 4796-4803
54. Steiner H., and Gerfen C.R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123 (1998) 60-76
55. Tang F., Costa E., and Schwartz J.P. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci U S A 80 (1983) 3841-3844
56. Trujillo K.A., Day R., and Akil H. Regulation of striatonigral prodynorphin peptides by dopaminergic agents. Brain Res 518 (1990) 244-256
57. Valenti O., Marino M.J., Wittmann M., Lis E., DiLella A.G., Kinney G.G., and Conn P.J. Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse. J Neurosci 23 (2003) 7218-7226
58. Wadenberg M.L., Soliman A., VanderSpek S.C., and Kapur S. Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology 25 (2001) 633-641
59. Walter B.L., and Vitek J.L. Surgical treatment for Parkinson's disease. Lancet Neurol 3 (2004) 719-728
60. Wardas J., Konieczny J., and Lorenc-Koci E. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats. Synapse 41 (2001) 160-171
61. Wichmann T., and DeLong M.R. Models of basal ganglia function and pathophysiology of movement disorders. Neurosurg Clin North Am 9 (1998) 223-236
62. Wittmann M., Marino M.J., Bradley S.R., and Conn P.J. Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata. J Neurophysiol 85 (2001) 1960-1968